Curie Cancer Carnot Institute : a partnership with Philips to enhance oncology patients’ care

11 2018
Les Carnot et les entreprises

Philips and Institut Curie (Curie Cancer Carnot Institute) have decided to invest more than 250 000 euros each in a partnership linked to the clinical use of the nuclear medicine PET scan Vereos, the first and only entirely digital PET/CT currently available on the market. Such a system can offer improved spatial resolution, significant gain in sensitivity and a better precision compared to standard analog systems.

Philips is honored to associate to Institut Curie (Curie Cancer Carnot Institute) in the framework of a long-lasting partnership whose purpose is to develop clinical research projects aiming at the improvement of cancer diagnostics and patient treatment. This project follows the acquisition by Institut Curie of a nuclear medicine digital system Philips Vereos, the first of its kind in the Paris region.

Read the press release